Takeaki Ishizawa Selected Research

Indocyanine Green (Cardio-Green)

11/2021	Laparoscopic anatomical liver resection for malignancies using positive or negative staining technique with intraoperative indocyanine green-fluorescence imaging.
2/2021	[Application of Fluorescence Imaging to Liver Cancer Surgery].
1/2021	Identification of liver lesions using fluorescence imaging: comparison of methods for administering indocyanine green.
10/2019	Late-Evening Carbohydrate and Branched-Chain Amino Acid Snacks Improve the Nutritional Status of Patients Undergoing Hepatectomy Based on Bioelectrical Impedance Analysis of Body Composition.
1/2019	Fluorescence Imaging for Minimally Invasive Cancer Surgery.
8/2018	Fluorescence-guided surgery for liver tumors.
12/2017	Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.
10/2017	Indocyanine green fluorescence imaging in colorectal surgery: overview, applications, and future directions.
1/2016	Laparoscopic deroofing for polycystic liver disease using laparoscopic fusion indocyanine green fluorescence imaging.
1/2015	Evaluation of hepatic perfusion in the liver graft using fluorescence imaging with indocyanine green.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeaki Ishizawa Research Topics

Disease

38	Neoplasms (Cancer) 07/2022 - 07/2006
20	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 02/2008
18	Neoplasm Metastasis (Metastasis) 04/2021 - 01/2006
8	Liver Neoplasms (Liver Cancer) 03/2021 - 06/2009
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
4	Pancreatic Fistula (Pancreatic Fistulas) 10/2018 - 05/2016
3	Fistula 01/2022 - 12/2018
3	Thrombosis (Thrombus) 04/2021 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 03/2021 - 01/2016
3	Hypertrophy 06/2020 - 03/2006
3	Body Weight (Weight, Body) 05/2019 - 08/2014
3	Ascites 05/2019 - 01/2009
3	Adenocarcinoma 10/2017 - 01/2014
3	Fibrosis (Cirrhosis) 11/2014 - 01/2013
2	Acute Cholecystitis 01/2022 - 10/2020
2	Cholecystitis 01/2022 - 10/2020
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2020
2	Portal Hypertension 11/2019 - 06/2008
2	Disease Progression 06/2019 - 04/2016
2	Colic (Abdominal Cramps) 01/2019 - 01/2017
2	Varicose Veins (Varicose Vein) 01/2019 - 07/2010
2	Cholangiocarcinoma 08/2018 - 01/2014
2	Hepatitis C 12/2014 - 01/2014
1	Hepatorenal Syndrome 07/2022
1	Inflammation (Inflammations) 01/2022
1	Pathologic Constriction (Stenosis) 01/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Pain (Aches) 01/2021
1	Postoperative Pain 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Hepatitis B 11/2019
1	End Stage Liver Disease 05/2019
1	Rupture 01/2019
1	Diarrhea 01/2019
1	Sinistral Portal Hypertension 01/2019
1	Stomach Neoplasms (Stomach Cancer) 06/2018

Drug/Important Bio-Agent (IBA)

19	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2021 - 06/2009
4	Amylases FDA Link 06/2018 - 11/2014
3	EnzymesIBA 01/2021 - 11/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 06/2014
2	lenvatinibIBA 07/2022 - 02/2022
2	Contrast MediaIBA 04/2021 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	DiureticsIBA 05/2019 - 01/2009
2	acarboxyprothrombin (PIVKA)IBA 01/2014 - 01/2013
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Bevacizumab (Avastin)FDA Link 07/2022
1	Sorafenib (BAY 43-9006)FDA Link 07/2022
1	atezolizumabIBA 07/2022
1	Pharmaceutical PreparationsIBA 07/2022
1	Capsules (Microcapsules)IBA 04/2021
1	perfluorobutane (AI 700)IBA 04/2021
1	Monounsaturated Fatty AcidsIBA 03/2021
1	phosphatidylethanolamineIBA 03/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	Histone MethyltransferasesIBA 01/2021
1	UNC 0638IBA 01/2021
1	hydroxide ionIBA 01/2021
1	MetalsIBA 10/2020
1	Phospholipases A1 (Phospholipase A1)IBA 01/2020
1	PhosphatidylserinesIBA 01/2020
1	LysophospholipidsIBA 01/2020
1	lysophosphatidylserineIBA 01/2020
1	Vasopressins (Vasopressin)IBA 05/2019
1	Tolvaptan FDA Link 05/2019
1	Spironolactone (Aldactone)FDA LinkGeneric 05/2019
1	AntidiarrhealsIBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Factor XIII (Coagulation Factor XIII)IBA 12/2018

Therapy/Procedure

25	Hepatectomy 04/2021 - 03/2006
9	Liver Transplantation 07/2022 - 01/2006
7	Pancreaticoduodenectomy 01/2020 - 03/2015
4	Operative Surgical Procedures 01/2021 - 11/2014
3	Therapeutics 07/2022 - 12/2014
3	Cholecystectomy 10/2020 - 07/2006
3	Intravenous Injections 08/2018 - 01/2014
2	Laparoscopic Cholecystectomy 01/2022 - 10/2020
2	Laparotomy 03/2021 - 12/2016
2	Photochemotherapy (Photodynamic Therapy) 02/2021 - 01/2014
2	Transplantation 01/2021 - 01/2021
2	Metastasectomy 01/2020 - 01/2016
2	Contraindications 11/2019 - 06/2008
2	Neoadjuvant Therapy 06/2019 - 05/2014
2	Drug Therapy (Chemotherapy) 06/2019 - 01/2018
2	Ligation 01/2019 - 10/2016
2	Surgical Instruments (Clip) 06/2018 - 01/2017
2	Pancreatectomy 01/2017 - 05/2016
2	Blood Transfusion (Blood Transfusions) 12/2014 - 08/2009
1	Molecular Targeted Therapy 07/2022
1	Surgical Staplers (Surgical Stapler) 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Organ Transplantation 01/2021
1	Stents 10/2020
1	Adjuvant Chemotherapy 01/2019
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 01/2019